EUVIMEDEUVIMED entdecken
Crossref

Role of Parameters in Whole Blood Analysis as in Indicator of Systemic Inflammation in Children with Rheumatic Valve Diseases

Lala Nurmammadova, Yilmaz Yozgat, Can Yilmaz Yozgat iD, Turkay Babayeva, Nigar Bayramova, Faraz Talebazadeh, Ertan Koç, Feyza Ustabas Kahraman, Ufuk Erenberk

Klinische Pädiatrie · 01.07.2026 · 238 (04) · 191-195

DOI: 10.1055/a-2367-9190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.07.2026. Verfasst von Lala Nurmammadova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics, Bezmialem Vakif University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Rheumatic Heart Disease, Myocarditis, Neopterin. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The most important cause of mortality and morbidity in acute rheumatic fever (ARF) is carditis and rheumatic heart disease (RHD). The aim of this study was to identify markers that may be indicators of chronic inflammation in whole blood analyses in pediatric patients with RHD who regularly received secondary deposilin prophylaxis.

Methods

In our study, 100 children with ARF aged between 4 and 18 years were followed up in the pediatric cardiology outpatient clinic of the patient group. The control group consisted of 100 healthy children of the same sex and age as the patient group. All children in the patient group regularly received deposilin prophylaxis every 21 days. Our study included many whole blood parameters that are reported in the literature to represent changes in chronic inflammatory diseases. These parameters were CRP, RDW, PDW, MPV and leukocyte subtypes, neutrophil, lymphocyte, monocyte counts and their ratios (neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte).

Results

Leukocyte count, lymphocyte count, basophil count, MLR and basophil count were significantly lower in the patient group than in the control group (p: 0.047, p: 0.023, p: 0.006). In addition, eosinophil count and RDW value were significantly higher in the patient group than in the control group (p: 0.043; p: 0.001).

Conclusion

In our study, low leukocyte, lymphocyte, basophil, MLR and higher eosinophil counts indicated that RDW could be effectively used as a marker for regular depositilin prophylaxis in pediatric patients with RHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rheumatic Heart DiseaseMyocarditisNeopterinHumansChildAdolescentFemaleChild, PreschoolMaleLeukocyte CountBiomarkersMean Platelet VolumeFollow-Up StudiesErythrocyte IndicesReference ValuesC-Reactive ProteinBlood Cell Count

Substanzen

BiomarkersNeopterinC-Reactive Protein

Autor:innen und Institutionen

  • Pediatrics, Bezmialem Vakif University, Istanbul, Turkey.
  • Pediatric Cardiology, Istanbul Medipol University, Istanbul, Turkey.
  • Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
  • Biostaticts, National Statistical Systems Training Academy, Istanbul, Turkey.
  • Pediatrics, Istanbul Medipol University, Istanbul, Turkey.

ORCID-Profile: Can Yilmaz Yozgat

Zitieren

APA

Nurmammadova, L., Yozgat, Y., Yozgat, C. Y., Babayeva, T., Bayramova, N., Talebazadeh, F., Koç, E., Kahraman, F. U., & Erenberk, U. (2026). Role of Parameters in Whole Blood Analysis as in Indicator of Systemic Inflammation in Children with Rheumatic Valve Diseases. Klinische Pädiatrie, 238(04), 191-195. https://doi.org/10.1055/a-2367-9190

Vancouver

Nurmammadova L, Yozgat Y, Yozgat CY, Babayeva T, Bayramova N, Talebazadeh F, et al. Role of Parameters in Whole Blood Analysis as in Indicator of Systemic Inflammation in Children with Rheumatic Valve Diseases. Klinische Pädiatrie. 2026;238(04):191-195. doi:10.1055/a-2367-9190

BibTeX
@article{Nurmammadova2026,
  author = {Nurmammadova, Lala and Yozgat, Yilmaz and Yozgat, Can Yilmaz and Babayeva, Turkay and Bayramova, Nigar and Talebazadeh, Faraz and Koç, Ertan and Kahraman, Feyza Ustabas and Erenberk, Ufuk},
  title = {Role of Parameters in Whole Blood Analysis as in Indicator of Systemic Inflammation in Children with Rheumatic Valve Diseases},
  journal = {Klinische Pädiatrie},
  year = {2026},
  volume = {238},
  number = {04},
  pages = {191--195},
  doi = {10.1055/a-2367-9190}
}
Kostenlos starten →